Innovations In Cancer Treatment And Research

Join us at the 2nd Annual Oncology Symposium

SATURDAY, SEPTEMBER 21, 2024
ELDORADO HOTEL & SPA

309 W. SAN FRANCISCO ST. • SANTA FE

Attendee Registration Fees:

Conference pricing includes admission to reception.

$100 Medical Doctors – MD, DO’s

$50 Advanced Practice Clinicians and Clinical Staff – PA, NP, RN, CRNA, CNM, Clinical Staff

Our Sponsors:

Pfizer Oncology PRESENTING SPONSOR Product Theatre Sponsor
Merck Event Sponsor	Johnson & Johnson Event Sponsor
Caris Life Sciences Event Sponsor	AstraZeneca Event Sponsor

Sponsorships/ Exhibitors:

Investment in a symposium sponsorship easily creates the best impact of your marketing dollars. We invite you to invest in us and bring your product to the attention of a captive audience.

$5000 – Sponsor / Exhibitor *
Sponsorship/ Exhibitor includes:

• Two (2) attendee registration tickets to the all-day cancer symposium and reception
• One table in the exhibit hall
• Two chairs in the exhibit hall
• Half-page ad in the Symposium Guide (sponsor to supply art)
• Your logo on event sponsor signage
• Your logo on the symposium webpage
• Sponsorship mention on CHRISTUS St. Vincent social media

*Exhibitors with more than (2) registered guests must pay $100 per additional sponsor/exhibitor attendee

Key Topics Include:

• Pancreas Cancer Early Detection with AI and Imaging
• Pancreas Cancer Early Detection with Biomarkers
• Advanced Endoscopic Detection for Pancreas Cancer
• Minimal Residual Disease in Cancer: Who and When to Measure CT-DNA
• Precision Guided Cancer Trials in GI Cancers
• GI Cancer Care in NNM
• Multi-Cancer Early Detection
• Taking Care of Patients with a Genetic Cancer Syndrome
• Undiagnosed Mass Program
• Chemoprevention for Moderate and High Risk of Breast Cancer
• Breast Cancer Care in NNM and High Risk Screening
• Proton and Carbon Ion Therapy: The New Kids on the Block for Radiation

 AGENDA

SPEAKERS

 

Michelle A. Anderson, M.D.

Associate Professor of Medicine, Division of Gastroenterology and Hepatology
Mayo Clinic, Phoenix, AZ

Dr. Michelle Anderson is Associate Professor and Senior Associate Consultant at Mayo Clinic Arizona. Her research and clinical career is focused on pancreatic diseases including chronic pancreatitis and pancreatic cancer. Using advanced endoscopy techniques including endoscopic ultrasound (EUS) and endoscopic retrograde cholangiopancreatography she cares for the full spectrum of benign and malignant pancreatic disorders. Dr. Anderson is an NIH-supported investigator for pancreatic cancer research. Dr. Anderson is Secretary for the ASGE, the leading endoscopy society in the US. She is the Co-Director of the ASGE EUS Diagnostic Course. Dr. Anderson speaks regularly on topics of biliary and pancreatic diseases and teaches advanced endoscopic techniques nationally and internationally. In the arena of chronic pancreatitis, Dr. Anderson led the development of National Guidelines in the care of patients with painful chronic pancreatitis.

 

Amani Jambhekar MD, MBA, FACS

Medical Director of Surgical Breast Oncology
CHRISTUS St. Vincent Regional Cancer Center, NM

Dr. Jambhekar attended Tulane University where she triple majored in English, Biology, and Psychology and earned a BA and BS. She received her medical degree from the University of Texas Health Science Center at San Antonio followed by general surgery residency at New York Presby­terian Brooklyn Methodist Hospital. Dr. Jambhekar is board certified in General Surgery and completed her fellowship in Surgical Breast Oncology at Columbia University Medical Center. She completed her MBA from the Kelley School of Business at Indiana University and received recognition as one of the top MBA graduates in the country. She is focused on building patient-centered multidisciplinary care models to bring the highest standards of surgical cancer treatment to New Mexico. She is also passionate about expanding genetic testing access for those who have a family history of cancer.
Dr. Jambhekar is committed to making her practice a place which empowers women.

 

Christina S. Wu, M.B., B.Ch., M.D.

Professor of Medicine, Division of Hematology Oncology
Mayo Clinic, Phoenix, AZ

Dr. Christina Wu is Professor in the Department of Internal Medicine, Division of Hematology/Oncology. She is a board-certified medical oncologist and specializes in the treatment of gastrointestinal cancers with a research focus in colorectal cancers and drug development. She holds professional memberships with American Society of Clinical Oncology, NRG Oncology, and Academic and Community Cancer Research United (ACCRU).

 

Rahul Pannala, M.D.

Professor of Medicine, Division of Gastroenterology and Hepatology
Mayo Clinic, Phoenix, AZ

Dr. Pannala is a Professor of Medicine, and Director of the Pancreas section at Mayo Clinic in Arizona. In addition, his other administrative roles include the Assistant Medical Director of Business Development and the Program Director for the Advanced Endoscopy fellowship program. His clinical practice is focused on pancreaticobiliary therapeutic endoscopy and endobariatric therapies. His research interests include pancreatic diseases and endoscopic bariatric therapies and he has published more than 100 peer reviewed scientific papers. He is pioneering the use of minimally invasive endobariatric therapies in patients undergoing organ transplantation. He also has a strong interest in medical device innovation and has multiple patents and novel devices in development. 

 

N. Jewel Samadder, MD, MSc, FRCPC, FACG, AGAF

Professor of Medicine, Division of Hematology Oncology and Clinical Genomics
Mayo Clinic, Phoenix, AZ

Dr. Samadder's focus are in the areas of hereditary cancer syndromes and endoscopic oncology. He directs the high risk cancer clinic at Mayo Clinic in Arizona, which provides genetic consultation and testing to patients with early onset cancer, rare cancers and hereditary cancers. Specifically this practice provides clinical management to patients with an inherited cancer syndrome, including (but not limited to) those with Lynch syndrome, FAP, MAP, Li Fraumeni syndrome, BRCA syndromes or any other cancer genetic syndrome. This clinic will provide patients with a single point of contact for all of their genetic testing and cancer screening, including genetic screening of relatives. His research focusses on the genetic epidemiology and outcomes of patients with hereditary cancer syndromes. Dr. Samadder is also leading multiple clinical trials using medications to prevent cancers in these patients. He is also leading efforts to increase genetic evaluation and testing of cancer patients throughout the entire Mayo health system.

 

Sandhya Pruthi, MD

Professor of Medicine, Division of General Internal Medicine and Breast Diagnostic Clinic
Mayo Clinic, Rochester, MN

Dr. Sandhya Pruthi received her M.D. degree from the University of Manitoba, Canada in 1990, and completed a Family Medicine residency at the Mayo Clinic in 1994.   She was the Director of the Breast Diagnostic Clinic at Mayo Clinic in Rochester, MN from January 2002 to July 2010.  She is a Consultant in the Department of General Internal Medicine and a Professor of Medicine.

Dr. Pruthi’s research and clinical expertise is in breast cancer prevention and management of women at increased risk for breast cancer, hereditary breast and ovarian cancer risk and providing pre-operative counseling to women newly diagnosed with breast cancer. She is the Mayo Clinic principal investigator on several national breast cancer prevention and biomarker trials aimed at reducing the risk of breast cancer.  She has collaborated in other women’s health trials studying integrative therapies for improving the quality of life of breast cancer survivors.

Dr. Pruthi is the Medical Director for the Division of Health Education and Content Services and serves as the Chief Medical Editor for MayoClinic.org website.  She is an Associate Medical Director for the Department of Development. Dr. Pruthi also serves as Medical Director for  new product curricula and content development in Continuous Professional Development. Professional Memberships from 2016-present: member Mayo Clinic Cancer Center and member Cancer Control Program/Prevention Committee for  Alliance For Clinical Trials in Oncology. Dr. Pruthi is Past President of the National Consortium of Breast Centers (NCBC).

 

Steven W. Ressler, M.D.

Assistant Professor of Medicine, Chair, Division of General Internal Medicine
Mayo Clinic, Phoenix, AZ

Dr. Ressler is an Internist in the division of General Internal Medicine who joined Mayo Clinic in 2002. Prior to coming to Mayo Clinic, he practiced in a rural setting at Payson Regional Medical Center, where he cared for Internal Medicine and Pediatric patients as an outpatient clinician, Hospitalist also serving as co-director of Adult Critical Care. Dr. Ressler earned an undergraduate degree at the University of Michigan and M.D. at Michigan State University, College of Human Medicine. He completed a combined Internal Medicine and Pediatrics residency at Good Samaritan Regional Medical Center (Banner) and Phoenix Children's Hospital.

Since joining Mayo Clinic, Dr. Ressler has cared for patients in Consultative Medicine, Executive Health, and International Medicine, also rotating on Hospitalist services for several years. He is chair of the Division of General Internal Medicine and Physician Ambassador to Canada for Mayo Clinic International. He also is the principal investigator for the Undiagnosed Mass Clinic and research program, which expedites diagnostic care for patients with a newly discovered mass. Dr. Ressler is originally from Ann Arbor, Michigan. He and his family love the Arizona desert and its endless opportunities for camping and hiking. They are also avid skiers and flock north at every opportunity.

 

Aadel A. Chaudhuri, M.D., Ph.D

Vice Chair of Translational Research and Senior Associate Consultant, Division of Radiation Oncology

Aadel Chaudhuri, MD, PhD, is the Vice Chair for Translational Research and Senior Associate Consultant in the Department of Radiation Oncology at the Mayo Clinic in Rochester, Minnesota. He additionally serves as the enterprise-wide co-director of the cancer individualized medicine office, and as an emerging leader at the Mayo Clinic Comprehensive Cancer Center. He is a physician-scientist with a lab that is dedicated to liquid biopsy research, and has been cited nearly 14,000 times, with an h-index of 35 (i10 index of 52).

Dr. Chaudhuri has graduated PhD students including those pursuing MD/PhD, and has successfully mentored physician-scientist postdoctoral trainees who have gone on to start their own research programs. He has been successful in obtaining external funding as PI (i.e. V Foundation V Scholar, NCI K08, NCI R01 x2, NIGMS R35), as have his mentees (i.e. NCI F30, NIGMS K08, Children’s Tumor Foundation Young Investigator Award).

Dr. Chaudhuri completed his MD at Stanford, PhD at Caltech, and BS degrees in Biology and Computer Science at MIT with a minor in Biomedical Engineering. He was mentored in the laboratory by Nobel Laureate Phillip Sharp when he was an undergraduate at MIT, and then mentored by Nobel Laureate David Baltimore at Caltech where he did his PhD in Biology, focusing on microRNAs in cancer. At MIT, he also competed on the varsity lightweight rowing team at the NCAA Division I level. He then completed his medical school and residency at Stanford University, where he did postdoctoral work with National Academy of Medicine member Maximilian Diehn, demonstrating that circulating tumor DNA serves as a powerful biomarker for molecular residual disease (MRD) after curative-intent localized lung cancer treatment. The study Dr. Chaudhuri led in Max’s lab was published in Cancer Discovery, has been cited over 800 times, and serves as a foundational paper in the ctDNA MRD field.

Dr. Chaudhuri’s laboratory at the Mayo Clinic focuses on the development and application of liquid biopsy cancer diagnostic technologies with the goal of more precisely personalizing solid tumor malignancy treatment, as well as detecting cancer sooner in rare tumor patients. His laboratory is funded by the National Cancer Institute, the National Institute of General Medical Sciences, the Children’s Discovery Institute, the Children’s Tumor Foundation, and the Melanoma Research Alliance.

 

Sameer R. Keoloe, M.D.

Assistant Professor of Radiation Oncology. Medical Director, West Region
Mayo Clinic Care Network, Phoenix, AZ

Sameer R. Keole, M.D., is a consultant in the Department of Radiation Oncology at Mayo Clinic and serves as the Medical Director of the Proton Beam Program for the Mayo Clinic Arizona campus. Dr. Keole also sees patients at Phoenix Children’s Hospital. Prior to joining Mayo Clinic in 2012, Dr. Keole served as medical director of ProCure Proton Therapy Center in Oklahoma City, Oklahoma, full partner in Radiation Medicine Associates, and as an adjunct assistant professor in the Department of Radiation Oncology at Oklahoma University Health Science Center.  Prior to working in Oklahoma, Dr. Keole was on faculty at University of Florida and was one of the original treating physicians at the University of Florida Proton Therapy Institute. He has held past Board positions in the American Society for Radiation Oncology (ASTRO) and in the American Society of Clinical Oncology (ASCO) CancerLinQ project.

Noted as a “Top Doctor” in both Oklahoma and Arizona, Dr. Keole has been instrumental in the development and use of proton therapy in cancer treatment. He speaks nationally and internationally on proton therapy. He has helped pioneer treatment techniques in prostate cancer, pediatric cancer, and gastrointestinal cancers.  He has written multiple book chapters and over eighty scientific articles.  At Mayo Clinic, he has held multiple leadership positions within the Cancer Center and Enterprise.

 

DeAnna M. Weaver, APRN, FNP, MSN

Instructor of Medical Genetics
Mayo Clinic, Arizona

DeAnna received her undergraduate degree in Nursing from Eastern Arizona College in 2010. In 2017 I received my Master’s Degree with Honors in Nursing from Walden University and my Family Medicine certification. As a Nurse Practitioner, I have worked in oncology research at Banner MD Anderson Cancer Center and joined Mayo Clinic in 2019 to support the Department of Clinical Genomics in an inherited cancer clinic. I have had the honor of working with patients who have rare cancer susceptibility genes and facilitate screening that aids in cancer prevention and early cancer detection. I am involved in several chemoprevention clinical trials as a sub-investigator and published a medical chapter on the role of genetic testing in breast cancer prevention. I hold the academic rank of Instructor in Medical Genetics at Mayo Clinic College of Medicine and Science.

 

Allison Donnell, ND, DOM

Physician CHRISTUS St. Vincent Supportive Care Medicine

Allison Donnell, ND, DOM is a licensed Naturopathic Doctor and Doctor of Oriental Medicine. She received her Doctorate of Naturopathic Medicine from Bastyr University in Kenmore, WA and her Master of Science of Oriental Medicine from Southwest Acupuncture College in Santa Fe, NM. She is a change-agent for New Mexico healthcare, and was instrumental in the licensing of Naturopathic Doctors in 2019.
She has held many leadership roles within the acupuncture and Naturopathic Medicine state associations, and is passionate about expanding access to integrative medicine within the traditional medical model. Dr. Donnell uses both traditional Chinese Medicine and Naturopathic Medicine modalities, offering patients a truly holistic model of care. Modalities offered include acupuncture, herbal medicine, body work, diet and lifestyle recommendations, extensive integrative lab testing, nutraceutical recommendations, and more. This medical model offers patients a safe approach for addressing many common complaints and “hard to treat” conditions.

As part of the care team, Dr. Donnell ensures that recommendations work synergistically with the treatment plan and goals of the patient’s primary physician. Dr. Donnell’s favorite conditions to treat are pain, migraines, chronic respiratory issues, digestive and urinary issues, immune and autoimmune issues.

 

Hannah Emery, DOM

Physician CHRISTUS St. Vincent Supportive Care Medicine

Hannah Emery, a licensed Doctor of Oriental Medicine, received her Bachelor of Arts from Skidmore College in Saratoga Springs, NY. She attained her Master of Acupuncture from Southwest Acupuncture College in Santa Fe, NM, where she graduated as class valedictorian. She is nationally certified by the NCCAOM as a Diplomate of Oriental Medicine.
Dr. Emery’s passion lies in fostering accessibility to Chinese medicine while cultivating balance between Eastern & Western medical philosophies. She aims to create a tranquil, supportive space for patients in which healing can occur. Offered modalities include acupuncture, Chinese herbal medicine, bodywork, nutritional and lifestyle therapy, and more. She enjoys drawing, hiking, and traveling in her free time.

 

Christi Capers, PharmD

GU field Medical Directors, Pfizer

Christi is a field medical director for Pfizer, one of the largest oncology pharmaceutical companies in the world.  She has over 26 years’ experience in various aspects of medical care.  For the last 16 years, her focus has been primarily in cancer care.  Currently, she works with healthcare providers, oncology researchers, and oncology advocacy groups to provide education and clinical trial opportunities in cancers involving the prostate, kidneys, and bladder for Pfizer.  Christi currently resides in Nashville, Tennessee where she has lived for most of her life.